The 2 Minute Medicine® Podcast

In this episode, we explore how artificial intelligence is continuing to move deeper into healthcare infrastructure and clinical practice. We begin with the Food and Drug Administration's review of an artificial intelligence tool designed to predict drug-induced liver injury during drug development. We then examine a new certification program launched by The Joint Commission focused on respons...

In this episode, we explore how social media, celebrity influence, and emerging science continue to shape healthcare conversations around the world. The article of the week comes from from Annals of Internal Medicine entitled “Dementia Risk After Recombinant Herpes Zoster Vaccination in Older Adults With a Recent Skilled-Nursing Facility Stay: A Target Trial Emulation.” In the second half, we take...

In this episode of the 2 Minute Medicine® Podcast, we explore major advances in precision medicine, beginning with the Phase 3 TALAPRO-3 trial demonstrating improved outcomes with talazoparib combined with enzalutamide in metastatic prostate cancer. We review new evidence from the COBRRA trial comparing apixaban and rivaroxaban, highlighting a significantly improved bleeding profile without loss o...

In this episode, we explore how social media and celebrity influence are reshaping health behaviors at scale. The article of the week comes from the New England Journal of Medicine and is entitled “Asundexian for secondary stroke prevention.”We start with the viral “Fibermaxxing” trend and its growing focus on microbiome health and satiety. We then examine how Jennifer Aniston’s longevity campaign...

In this special deep-dive episode of the 2 Minute Medicine® Podcast, we explore the rapid transformation of artificial intelligence across the healthcare landscape, beginning with Roche’s launch of a large-scale AI factory designed to accelerate drug discovery and manufacturing. We review how NVIDIA-powered systems and “Lab-in-the-Loop” models are enabling real-time refinement of biological predic...

In this episode of the 2 Minute Medicine® Podcast, we explore a major public health moment as White House Chief of Staff Susie Wiles’ breast cancer diagnosis drives a national surge in screening awareness and reinforces the importance of early detection. We review new data on firearm acquisition trends following the COVID-19 pandemic, highlighting shifting demographics and implications for public...

In this special deep-dive episode of the 2 Minute Medicine® Podcast, we explore the remarkable evolution of GLP-1 receptor agonists from injectable diabetes therapies to some of the most influential drugs in modern medicine. We review the landmark clinical trials behind semaglutide and tirzepatide that transformed expectations for medical weight loss. The episode then examines the emerging race to...

This  Pharma Roundup  episode reviews four major regulatory and clinical developments shaping early 2026. It begins with the Food and Drug Administration approval of Nuzolvence (zoliflodacin), a first-in-class oral antibiotic for uncomplicated gonorrhea offering a needle-free alternative amid rising antimicrobial resistance. The episode then covers the approval of Yartemlea for hematopoietic stem...

In this episode, we lead with our article of the week from the New England Journal of Medicine examining the noninferiority of a single-dose HPV vaccine compared with the standard two-dose regimen. We then dive into a detailed edition of  The Scan , discussing how oral semaglutide is reshaping routine obesity visits and the real-world challenges of daily medication adherence. The conversation turn...

In this episode of the 2 Minute Medicine Podcast: Pharma Roundup, we explore how innovation, regulation, and global strategy are reshaping the pharmaceutical landscape. We begin with the FDA’s approval of Enbumyst, the first intranasal loop diuretic for edema, offering patients with heart, kidney, or liver disease a faster and more convenient alternative to oral or intravenous therapy. Next, we tu...

In this episode of the 2 Minute Medicine Podcast: AI Roundup, we examine how artificial intelligence is rapidly transitioning from research to real-world medical impact. We begin with Eli Lilly’s launch of TuneLab, a billion-dollar federated AI platform that opens the company’s research models to smaller biotech partners, marking a major shift toward collaborative drug discovery. Next, we explore...

Welcome to this week’s episode of The 2 Minute Medicine Podcast, where practicing physicians break down the latest in clinical research and health care news. We begin with our Article of the Week, a  New England Journal of Medicine  study titled “Global Effect of Cardiovascular Risk Factors on Lifetime Estimates,” which analyzes data from more than two million participants across 39 countries. The...

In this episode, we lead with our article of the week from the  New England Journal of Medicine , “Tirzepatide as Compared with Semaglutide for the Treatment of Obesity.” We then cover the FDA’s authorization of updated, limited-access COVID-19 boosters and ongoing concerns about uptake. Next, we track the seasonal surge in West Nile virus during peak mosquito activity. We also discuss John Cena’s...

In this episode of the 2 Minute Medicine Podcast: AI Roundup, we explore how artificial intelligence is reshaping health care at every level. We begin with Illinois’ landmark law banning unsupervised AI in mental health care, the first of its kind in the U.S. We then spotlight Abridge’s $300 million funding round, as its clinical AI scribe continues to scale across more than 150 health systems. Ne...

In this episode, we start with Doximity’s nationwide launch of a free AI scribe for every U.S. clinician, designed to cut charting time in half and ease burnout, with analysts predicting it could spark a major pricing shake-up in the medical dictation market. Next, we spotlight Ultromics, an Oxford spin-out that just raised $55 million to expand its FDA-cleared cardiac-ultrasound AI, which detects...

In this episode, we begin with discussing our article of the week which comes  from JAMA Network Open and is entitled “Oral vancomycin for prevention of recurrent clostridioides difficile infection: A randomized clinical trial.” Then, we discuss Venus Williams’ triumphant return to tennis and her advocacy for fibroid awareness and insurance reform. Then we turn to Matt McGorry’s long COVID journey...

In this episode, we open with Jessie J’s stage-I breast-cancer disclosure and the immediate surge in mammogram bookings that followed across the United Kingdom. Next, we dive into Olympic swimmer Kyle Chalmers’s frank discussion of anxiety and his virtual workshops that now reach hundreds of young athletes. We then explore Real Housewives star Dolores Catania’s atrial-fibrillation ablation and her...

Welcome to this week’s Pharma Roundup. In this episode, we begin with a peri operative immunotherapy that lowers gastric cancer relapse, move to an FDA decision that lets a prostate cancer pill skip chemotherapy prerequisites, continue with a wearable injector that trims myeloma treatment to five minutes, and finish with the agency’s choice to drop extra safety hurdles so more hospitals can delive...

In this episode, we kick things off with a deep dive into the UK’s miONCO-Dx trial, an AI-powered blood test that detects 12 common cancers with 99 % accuracy and could one day replace colonoscopies. Backed by £2.4 million in NHS funding and already analyzing its first wave of samples, the study exemplifies Britain’s push for tech-driven early cancer detection. Then in the second half of the episo...

In this episode, we begin with a discussion about our article of the week. Our article of the week comes from  The New England Journal of Medicine  and is entitled “Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons.” Then in the second half of the episode, we begin with a discussion about Billy Joel’s newly disclosed diagnosis of normal pressure hydrocephalus and what h...

In this episode, we kick things off with our article of the week which comes from JAMA Network Open and is entitled “Cannabis Use and Misuse Following Recreational Cannabis Legalization” Then, we take a look at the devastating impact of Cyclone Mocha on health systems in Myanmar and Bangladesh. We explore how natural disasters don’t just damage infrastructure—they also cripple access to care and m...

In this episode, we begin with a discussion about our article of the week.,Our article of the week comes from The Lancet Oncology and is entitled “Low-dose CT for lung cancer screening in a high-risk population (SUMMIT): a prospective, longitudinal cohort study.” Then in the second half of the episode, we begin with a discussion about a new, three-in-one therapy for endometriosis. Then we take a c...

In this episode, we begin with a discussion about our article of the week, which comes from the New England Journal of Medicine and is entitled “Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections”. the United States’ measles outbreak. Then in the second half of the episode, we take a closer look at how President Trump’s tariffs may affect healthcare both within the U...

In this episode, we discuss our article of the week  from JAMA Network Open which is entitled “Patient complexity, social factors, and hospitalization outcomes at academic and community hospitals.” Then, we discuss the positive relief on pain and anxiety that immersive imagery and hypnotic techniques can provide patients with. Further, we discuss the TikTok ban, the impact of smart devices on our...

In this episode, we begin with a discussion about a recent surge in human metapneumovirus cases in China. Then we take a closer look at the United States Surgeon General’s new recommendations on alcohol intake. After that, we examine recent developments in the avian flu outbreak. Finally, we discuss how strenuous exercise can be detrimental to women’s health. We are excited to share that the 2nd e...